Quit-Smoking Study for Native Hawaiians
Key facts
- Who runs it
- University of Hawaii
- Where
- Honolulu, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 75 people, planned
- Started
- 1 Apr 2026
- Expected to end
- 1 Apr 2028
- Type of study
- Interventional, 3 groups
- Treatments tested
- Nicotine Polacrilex Gum (2 mg)
- Cognitive Behavioral Group Therapy (CBGT)
- Record updated
- 31 March 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- Self-identifies as full or part Native Hawaiian
- Between the ages of 18 and 80 years, inclusive, at eligibility screening
- Currently smoking ≥5 cigarettes per day (self-report) at eligibility screening
- Has smoked more than 100 cigarettes in his/her lifetime (self-report)
- Affiliated with one of three (3) designated public housing complexes at which the intervention will be delivered: Kalihi Valley Homes, Kuhio Park Terrace, Mayor Wright Housing
- Willing to make a smoking cessation attempt the day after the first study visit (i.e., date of consent)
- Willing to engage in use of nicotine replacement therapy gum (NRT gum) and/or smoking cessation-focused cognitive-behavioral group therapy (CBGT)
- Participant must agree to not use any form of pharmacotherapy (i.e., prescription medication or any form of nicotine replacement therapy) to try to quit smoking during the 12-week study period, except as specifically assigned to his or her study condition and distributed by the research team
- Participant must agree to not use other tobacco or nicotine products (e.g., cigars, little cigars, electronic cigarettes, nicotine pouches) during the 12-week study period
- Participant must agree to not smoke or vape cannabis (i.e., marijuana) during the 12- week study period
- Participant must agree to not use other illicit drugs, including prescription opioid medications, during the 12-week study period
- Participant must be able to speak, read, and write English
- Participant must be able to understand the study procedures and agree to participate in the study by providing written informed consent
Who cannot take part
- Use of pharmacotherapy (i.e., prescription medication or any form of nicotine replacement therapy) to try to quit smoking in the 30 days prior to eligibility screening
- Use of other tobacco or nicotine products (e.g., cigars, little cigars, electronic cigarettes, nicotine pouches) in the 30 days prior to eligibility screening
- Use of smoked or vaped cannabis (i.e., marijuana) in the 30 days prior to eligibility screening
- Use of other illicit drugs, including prescription opioid medications, in the 30 days prior to eligibility screening
- Pregnant or nursing, or planning to become pregnant or breastfeed in the next three (3) months
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Tobacco use disorder or smoking cessation
Where in United States
- University of Hawai'iHonolulu, United StatesContact: Pallav Pokhrel, PhD, MPHNot yet recruiting
About the trial
What the trial wants to find out
This study aims to help Native Hawaiian adults quit smoking by testing two common methods: nicotine gum and group-based counseling. Participants will be assigned to one of three groups: (1) nicotine gum only, (2) group counseling only, or (3) a combination of both. The study will take place at public housing sites on O'ahu. Researchers will check if these approaches-alone or in combination-can support people in successfully quitting smoking. The goal is to find out which method works best and is most acceptable in this community.
The 3 groups in the trial
- NRT Gum OnlyTreatment being tested
Participants receive nicotine gum (2 mg) according to a 12-week FDA-approved tapering schedule. No counseling is provided.
Treatment: Nicotine Polacrilex Gum (2 mg)
- CBGT OnlyTreatment being tested
Participants attend six weekly sessions of cognitive-behavioral group therapy (CBGT) for smoking cessation. No nicotine gum is provided.
Treatment: Cognitive Behavioral Group Therapy (CBGT)
- CBGT + NRT GumTreatment being tested
Participants receive both nicotine gum (2 mg, tapered over 12 weeks) and attend six weekly CBGT sessions for smoking cessation.
Treatment: Nicotine Polacrilex Gum (2 mg) and Cognitive Behavioral Group Therapy (CBGT)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smoking Cessation Among Native Hawaiians: A Test of Pharmacotherapies and Group-Based Counseling
- Criteria questions
- Built from NCT07075575, who can take part
- Record updated
- 31 March 2026